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Abstract – Dendritic cells (DC) represent a heterogeneous cell family of major importance for innate
immune responses against pathogens and antigen presentation during infection, cancer, allergy and
autoimmunity. The aim of the present study was to characterize canine DC generated in vitro with respect to
their phenotype, responsiveness to toll-like receptor (TLR) ligands and T-cell stimulatory capacity. DC were
derived from monocytes (MoDC) and from bone marrow hematopoietic cells cultured with either Flt3-
ligand (FL-BMDC) or with GM-CSF (GM-BMDC). All three methods generated cells with typical DC
morphology that expressed CD1c, CD11c and CD14, similar to macrophages. However, CD40 was only
found on DC, CD206 on MU and BMDC, but not on monocytes and MoDC. CD1c was not found on
monocytes but on all in vitro differentiated cells. FL-BMDC and GM-BMDC were partially positive for
CD4 and CD8. CD45RA was expressed on a subset of FL-BMDC but not on MoDC and GM-BMDC.
MoDC and FL-DC responded well to TLR ligands including poly-IC (TLR2), Pam3Cys (TLR3), LPS
(TLR4) and imiquimod (TLR7) by up-regulating MHC II and CD86. The generated DC and MU showed a
stimulatory capacity for lymphocytes, which increased upon maturation with LPS. Taken together, our
results are the basis for further characterization of canine DC subsets with respect to their role in
inﬂammation and immune responses.
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1. INTRODUCTION
Dendritic cells (DC) represent a complex
family of cells comprised of multiple subsets
with different origin, anatomical localization
and function [20]. Besides their particular abil-
ity to act as sentinels of the immune system and
sensing invading pathogens and danger, they
are most effective in antigen presentation and
able to prime naive T cells [32], as well as
regulating the orientation of distinct T-cell
responses [20]. Their functioning is most criti-
cal for resistance to pathogens and tumors.
DC express different pattern recognition recep-
tors like toll-like receptors (TLR) for respond-
ing to danger and pathogen associated
molecular patterns and internalizing of patho-
gens, and C-type lectin receptors for the inter-
nalizing of pathogens [19, 36]. To fulﬁl their
role as sentinels, DC are not only present in
the blood and lymphoid tissue [23]b u ta l s o
throughout the skin [25] and mucosa [28]u n d e r
steady state conditions. Recent evidence from
the mouse has demonstrated that DC have
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present in lymphoid tissue and blood originate
from an early DC progenitor population and
depend on the haematopoietic cytokine Fms-
like tyrosine kinase 3 ligand (Flt3L), whereas
under inﬂammatory conditions DC can also
originate directly from monocytes in a granulo-
cyte-macrophage colony-stimulating factor
(GM-CSF)-dependent manner [2, 23]. In addi-
tion, it appears that the origin of DC is organ-
dependent. Particular subsets of DC in mucosal
tissue including the gut and lung are partially of
monocyte origin [37].
In order to translate this knowledge into the
ﬁeld of canine immunology, this study was
aimed at phenotypically characterizing and
comparing canine DC generated from bone
marrow haematopoietic cells under the inﬂu-
ence of Flt3L or GM-CSF with DC and macro-
phages derived from blood monocytes (MoDC
and MU, respectively), and identifying discrim-
inatory markers for each cell population. In
order to characterize how canine DC would
respond to pathogens, we analyzed their
responses to different TLR ligands. To this
end we established culture systems for canine
DC and MU based on protocols published for
mice, humans and pigs to generate MoDC
[3, 7–9, 17, 32, 39, 43]a n db o n em a r r o w
haematopoietic cell-derived DC (BMDC) as
documented for humans [29], mice [22], rats
[35], bovines [15] and pigs [8].
2. MATERIALS AND METHODS
2.1. Animals
B l o o dw a sd r a w nf r o m2 5h e a l t h yp r i v a t e l y
owned dogs with the owner’s written consent. Five
l a b o r a t o r yB e a g l e su s e da sc o n t r o ld o g si nt o x i c o l o g -
ical studies (Novartis Animal Health, Basel, Switzer-
land) were used as a source of bone marrow. All
procedures were approved by the local animal wel-
fare authorities.
2.2. Isolation of PBMC, monocytes and bone
marrow hematopoietic cells
PBMC were isolatedfromfreshlydrawnblood an-
ticoagulated with EDTA by histopaque (1.077 g/mL;
Sigma-Aldrich,Buchs,Switzerland)gradientcentrifu-
gation as described previously [18]. Monocytes,
deﬁnedasCD14
+cells,wereisolatedfromfreshlypre-
paredPBMCwiththeMACSsystem(MiltenyiBiotec,
Bergisch Gladbach, Germany) according to the manu-
facturer’s instructions. Brieﬂy, after PBMC isolation,
the cells were counted and incubated with anti-CD14
mAB CAM36A (see Tab. I). After washing with
buffer, secondary goat anti-mouse microbeads were
applied and the cells were placed onto an MS column.
After several washing steps, CD14
+ monocytes were
obtained with a purity of 92–98%, controlled by ﬂow
cytometry (FCM).
Bone marrow hematopoietic cells were obtained
from the humerus of freshly euthanized dogs. The
marrow was ﬂushed with phosphate buffered saline/
0.03% EDTA (PBS-EDTA) at room temperature
and overlaid on histopaque for gradient centrifugation
to deplete granulocytes and erythrocytes [8]. The
cells were washed three times with PBS-EDTA at
4  C.
2.3. Cell culture
For macrophage differentiation, isolated CD14
+
monocytes were resuspended at 1 · 10
6 cells/mL in
phenolred-free DMEM high in glucose (PAA Labo-
ratories GmbH, Chemie Brunschwig AG, Basel,
Switzerland) supplemented with 20% autologous
serum. Recombinant human GM-CSF (rhuGM-
CSF; 15 ng/mL; kindly donated by Novartis Pharma,
Vienna, Austria) was added and the cells were incu-
bated at 37  C in a humiﬁed atmosphere with 5%
CO2 for 6 days. Half of the medium was replaced
on days 2 and 4.
To generate MoDC, puriﬁed monocytes were
resuspended at 1 · 10
6 cells/mL in serum free
AIM V MED medium (Invitrogen, Lubio Science,
Lucerne, Switzerland) and cultured at 37  Cf o r
6 days in the presence of 15 U/mL recombinant
canine IL-4 prepared in our laboratory and 15 ng/mL
rhuGM-CSF. Half of the medium was replaced on
days 2 and 4.
Isolated bone marrow haematopoietic cells were
cultured at 5 · 10
5/mL for 12 days in IMDM
(PAA) with 10% v/v FBS, 100 U/mL penicillin
(Sigma), 100 lg/mL streptomycin (Sigma), 2 mM
L-glutamine (Sigma) and 50 ng/mL of either feline
Flt3-ligand (Flt3L) (R&D Systems), porcine recom-
binant Flt3L (in house), human Flt3L (PeproTech
EC Ltd., London, UK) or 50 ng/mL rhuGM-CSF.
Half of the medium was replaced twice per week.
For each dog, the cells were cultured with both feline
Flt3L and rhuGM-CSF, respectively.
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TLR ligands including Pam3Cys-SK4 at 10 lg/mL
(Pam3C, TLR2 ligand; EMC microcollections,
Tu ¨bingen, Germany), polyinosinic-polycytidylic acid
potassium salt (PIC, TLR3 ligand; Sigma), Imiqui-
mod at 5 lg/mL (Imi, TLR7 ligand; Invivogen,
San Diego, USA), CpG oligonucleotide ODN
2395 at 5 lg/mL (TLR9 ligand; Invivogen), and
LPS at 1 lg/mL (from E. coli 0128:B12, TLR4
ligand; Sigma). CpG ODN 2395 was chosen on the
basis of its capacity to induce IFN-type I in canine
PBMC. The responsiveness to these TLR ligands
was analyzed after 24 h of culture in terms of their
impact on MHC class II (MHC II) and the costimu-
latory molecule CD86.
2.4. Cloning of recombinant canine IL-4
We cloned canine IL-4 as described previously
[33]. Brieﬂy, PBMC were stimulated for 18 h with
concanavalin A (10 lg/mL), total RNA was isolated
using the RNAeasy-kit (Qiagen, Basel, Switzerland).
After reverse transcription with oligo-dT primary and
Omniscript RT (Qiagen), the canine IL-4 gene was
ampliﬁed by standard polymerase chain reaction
(PCR) using primers designed based on the published
sequence of IL-4 (GenBank: AF187322.1). The PCR
product was subsequently cloned into the pEAK-HIS
expression vector. IL-4 was produced in HEK-293
cells using calcium-phosphate transfection. The bio-
logical activity was quantiﬁed using TF1 cells.
2.5. Phenotyping
All monoclonal antibodies (mAB) used are listed
in Table I. To determine the phenotype of mono-
cytes, PBMC were double stained with aCD14
(TU ¨K4 or CAM36A) in combination with all other
mAB followed by anti-mouse or anti-rat isotype spe-
ciﬁc ﬂuorescein isothiocyanate (FITC) or phycoery-
thrin (PE) conjugated goat F(ab’)2 Igs (Southern
Biotech, Birmingham, USA). Macrophages and
DC (only harvested non-adherent cells) were pheno-
typed by single labeling. Fluorescence intensities
were quantiﬁed using a LSRII ﬂow cytometer
(BD Biosciences, San Jose, CA, USA) and data
were processed with FlowJo software (Tree Star,
Ashland, OR, USA).
2.6. T-cell stimulation assays
For mixed lymphocyte reactions (MLR), lympho-
cytes (CD14-depleted PBMC) were stained with a
ﬁnal concentration of 0.5 lM CFSE (Vybrant1
CFDA SE Cell Tracer Kit, Invitrogen, OR, USA).
The lymphocytes were washed 4 times with DMEM
10% v/v FBS. Half of the cultured DC and macro-
phages were stimulated for 24 h with 1 lg/mL
Table I. Monoclonal antibodies used for surface molecule labeling.
Clone Antigen Target species Source
CA13.1E4 CD4 Canine Serotec
a
YKIX322.3 CD5 Canine Serotec
CA9.JD3 CD8 Canine Serotec
Ca13.9H11 CD1c Canine P. Moore
b
CA16.3E10 CD11b Canine P. Moore
CA11.6A1 CD11c Canine P. Moore
CAM36A CD14 Bovine VMRD
c
Tu ¨k4-RPE-Cy5 CD14 Human Serotec
CA4.1D3 CD45RA Canine P. Moore
CA24.5D4 CD80 Canine P. Moore
CA24.3E4 CD86 Canine P. Moore
CA2.1C12 MHC II Canine P. Moore
3.29B1.10 CD206 Human Beckman Coulter
d
LOB7/6 CD40 Human Serotec
a Serotec, Oxford, UK.
b Peter Moore, University of Davis, CA, USA.
c VMRD, Pulman, USA.
d Beckman Coulter, Roissy, France.
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conditions but without stimulants. CFSE-labeled
lymphocytes were resuspended in RPMI (Gibco,
Invitrogen) supplemented with 10% v/v FBS,
100 U/mL penicillin (Sigma) and 2 mM L-glutamine
(Sigma) and seeded in triplicates of 2 · 10
5 cells in
96-well U-bottom plates (Corning, Vitaris, Baar,
Switzerland) together with titrated numbers of DC
or macrophages. After 5 days, the cells were stained
with CD5 and anti-rat IgG PE-conjugated goat
F(ab’)2 Ig (Jackson Immuno Research, West Grove,
USA). Proliferation of CD5 positive cells, based on
the CFSE proﬁle, was assessed by FCM as described
before [18].
2.7. Statistical analysis
The relative increase of the mean ﬂuorescent
intensity was calculated by dividing the stimulated
by the unstimulated value. Normal distribution was
assumed and a one-sample t-test was used to test
for signiﬁcant difference to 1. Statistical signiﬁcance
was considered for p  0.05. The difference of the
stimulatory capacity between unstimulated versus
stimulated cells in an MLR was also assumed to
be normally distributed and was tested with a
one-sample t-test using NCSS 2004 software (NCSS,
Kaysville, Utah, USA) as well.
3. RESULTS
3.1. Generation of MoDC
In our hands, published cell isolation proto-
cols and corresponding culture conditions for
canine MoDC differentiation [7, 39] did not
consistently generate cells with dendritic mor-
phology and some cultures had a low viability
or a high proportion of granular cells (data
not shown). In contrast, using modiﬁed condi-
tions as described in Materials and Methods
section, non-granulated cells with high viability
and dendritic morphology were consistently
generated. Within 24 h, monocytes adhered
well, started to spread and appeared larger.
After 3 days of culture, non-adherent cells accu-
mulated possessing dendritic extensions pro-
truding from the surface (Fig. 1A). These
cells typically formed small clusters (Fig. 1B).
Cells with this morphology further increased
up to 6 days of culture. In contrast, in the
absence of IL-4 strongly adhering cells with
typical macrophage morphology with a large,
granular cytoplasm, and a rufﬂed surface, could
be observed (Fig. 1C).
AB C
Figure 1. Cell morphology of canine MU and MoDC. (A, B) MoDC generated from monocytes cultured
with human GM-CSF and canine IL-4. (A) Cells with dendritic extensions; (B) cluster of MoDC. (C) MU
obtained from CD14
+ monocytes after 6 days of culture in serum-free medium supplemented with human
GM-CSF.
Figure 2. Phenotype of monocytes, monocyte-derived MU (MF) and MoDC. The ﬁlled histogram
represents the conjugated controls, the overlaid lines the expression of the markers of unstimulated (dashed
line) or LPS (10 lg/mL) stimulated cells (solid line) (only for MU and MoDC). The numbers give the
percentages of positive cells calculated with the Overtone algorithm of the Flowjo software. Data are
representative of 5 independent experiments. A statistical signiﬁcance for the LPS stimulation is indicated
by a * (p < 0.05, n = 5, assessed for CD11c, CD45RA, CD14, MHC II, CD80, CD86, CD206 and CD40).
c
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MU and MoDC
As shown in Figure 2, monocytic cells
expressed the lineage markers CD11c and
CD14 but were negative for CD4, CD5 (data
not shown) and CD8. In contrast to differenti-
ated cells, monocytes differed from MU and
MoDC only by the lack of CD1c, CD206 (man-
nose receptor) and CD40 expression. MU had a
similar phenotype to MoDC, but higher expres-
sion of CD11b, CD11c, CD14 and CD45RA.
CD206 was only found on MU,w h e r e a s
CD40 was restricted to MoDC. Upon LPS stim-
ulation of MU, the expression of costimulatory
molecules such as CD80 and CD86 but not of
MHC II increased. In contrast, LPS-stimulated
MoDC displayed signiﬁcantly higher MHC II,
CD40, CD86 and CD80 expression (Fig. 2).
3.3. Generation of BMDC
Since no canine Flt3L was commercially
available, we tested the cross-reactivity of sev-
eral species. In contrast to feline Flt3L, the
human cytokine did not support any growth
and differentiation of DC from bone marrow
haematopoietic cells (data not shown). The
bone marrow haematopoietic cell cultures
supplemented with either GM-CSF or Flt3L
differentiated into large cells with dendritic
morphology within 10 to 12 days (termed
GM-BMDC and FL-BMDC, respectively).
Besides DC, a population of non-adherent
smaller and round cells, which were presum-
ably immature precursor cells, was visible.
In addition, adherent cells with macrophage-
as well as stroma-cell morphology developed.
These cells were not harvested and further
investigated in the present study. Based on the
forward/side scatter characteristics, we found
two populations of non-adherent cells: small
cells with low forward and side scatter and lar-
ger cells with high scatter values. The latter
population increased upon stimulation with
LPS (Fig. 3A). When compared to FL-BMDC,
the majority of GM-BMDC had a high scatter
(Fig. 3A), relating to their bigger size and
higher degree of differentiation as observed by
light microscopy (data not shown).
3.4. Comparative phenotype of BMDC
In contrast to MoDC, GM-BMDC and
FL-BMDC with high forward and side scatter
(SC
high)expressedCD4andCD8(Fig.3B).Sim-
ilar to monocyte-derived cells, CD1c were
expressed on the majority of GM-BMDC and
allFL-BMDC(Fig.3B).CD11bshowedahigher
expression on the BMDC when compared to
MoDC. Similar to MoDC, CD11c and CD14
were expressed on GM-BMDC and on SC
high
FL-BMDC, althoughthepresumablyless differ-
entiated SC
low FL-BMDC were mostly negative
for these markers. In contrast to MoDC, CD11b
was expressed at high levels on BMDC.
CD45RA was only expressed at high levels on
SC
low FL-BMDC.CD206 was highlyexpressed
on GM-BMDC but weakly on FL-BMDC. For
thematurationmarkers,itwasinterestingtonote
that in contrast to FL-BMDC, GM-BMDC pos-
sessedamorematurephenotypewithhighlevels
of MHC II, CD86 and CD40, with little increase
after LPS stimulation. Only the expression of
CD80 was highly enhanced by LPS. In contrast,
LPS treatment of FL-BMDC potently enhanced
the expression of all four maturation markers in
theSC
high,butnotinthelessdifferentiated,SC
low
Figure 3. Phenotype of BMHC-derived DC. (A) Forward-side scatter plots of FL-BMDC and GM-BMDC.
In FL-BMDC a region for cells with low scatter (SC
low) and with high scatter (SC
high) was created.
(B) Histogram plots for the markers indicated for cells in the gate deﬁned in (A). The ﬁlled histograms
represent the conjugate controls, the overlaid lines the expression of the markers of unstimulated (dashed
line) or LPS (10 lg/mL) stimulated cells (solid line). The numbers are percentages of positive cells
calculated with the Overtone algorithm with the Flowjo software. Data are representative of 5 independent
experiments. The * indicates a statistically signiﬁcant LPS-induced increase of the MFI (p < 0.05;
calculated for CD11c, CD45RA, CD14, MHC II, CD80, CD86, CD206 and CD40). (A color version of this
ﬁgure is available online at www.vetres.org.)
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on CD1c expression.
3.5. Response of canine DC to various
TLR ligands
As shown in Figures 2 and 3B, dependent on
the type of culture, canine DC responded to LPS
(TLR4 ligand) by up regulation of MHC II and
costimulatory molecules. We further investi-
gated this function of DC using additional
ligands for TLR2, TLR3, TLR7 and TLR9.
MoDC from all tested dogs reacted to stimula-
tion of TLR2, -3 and -4, with a statistically sig-
niﬁcant up regulation of CD86 and MHC II
(Fig. 4 and Tab. II). The MHC II up regulation
after stimulation through TLR7 was lower, but
alsosigniﬁcant(p = 0.029). In contrast, stimula-
tion through TLR9 was inconsistent with up-
and also down-regulation of both CD86 and
MHC II, dependent on the experiment. With
the BMDC, more variation with cells obtained
from different dogs was observed (Fig. 4). Nev-
ertheless, with FL-BMDC we observed a con-
sistent increase of CD86 and MHC II
expression upon stimulation with ligands to
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Figure 4. Phenotypic maturation of MoDC, FL-DC and GM-DC upon stimulation with different TLR
ligands in terms of up regulation of MHC II and CD86. The different DC cultures were stimulated for 24 h
with Pam3Cys-SK4 (Pam3C, 10 lg/mL), polyinosinic-polycytidylic acid potassium salt (PIC, 10 lg/mL),
LPS (1 lg/mL), Imiquimod (Imi, 5 lg/mL) or CpG 2395 (5 lg/mL). The ratios of the MFI of stimulated
and unstimulated cells were calculated and tested for signiﬁcance (n =5 ; * p value of 0.01–0.05;
**p > 0.01). (A color version of this ﬁgure is available online at www.vetres.org.)
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also in this cell population CpG stimulation
was not consistent in its inﬂuence on MHC II
and costimulatory molecules. As already
described for Figure 3B, GM-BMDC reacted
less well to stimulation by ligands for TLR2,
TLR3, TLR4 and TLR7. Here, the increase of
MHC II and CD86 expression was only signif-
icant for cells stimulated with PIC, LPS and im-
iquimod (Fig. 4, Tab. II). Stimulation with
Pam3C induced a statistically signiﬁcant
increase only of MHC II expression.
3.6. T-cell stimulatory capacity
With respect to the capacity to stimulate
allogeneic T lymphocytes, MU showed a
comparable activity to MoDC (p > 0.05), but
the monocyte-derived cells were less potent
than BMDC (p < 0.01). Within BMDC, the
GM-BMDC were more potent in this function
than FL-BMDC (p < 0.02). With all four cell
types, thestimulatedcells showed a signiﬁcantly
higher T-cell stimulatory capacity than their
unstimulated counterparts (p <0 . 0 0 2 ;Fig. 5).
4. DISCUSSION
The dog has an increasing importance as an
alternative non-murine animal model for several
immunological disorders, such as atopic derma-
titis [30], asthma [5], hypothyroidism [13], dia-
betes mellitus [31], autoimmune haemolytic
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Figure 5. Comparative T-cell stimulatory capacity of the different MU and differentially generated DC.
Unstimulated and LPS-stimulated MU/DC were tested in mixed lymphocyte reactions. MU and DC were
cultured at ratios of 1:10 (blue), 1:30 (red); 1:90 (green) with lymphocytes. The * indicates a statistically
signiﬁcant higher activity of LPS-stimulated cells. The p value for MU was 0.04, for MoDC 0.02,
FL-BMDC 0.05 and for GM-BMDC 0.006. Standard deviations of triplicates are shown and the data are
representative of three independent experiments. (A color version of this ﬁgure is available online at
www.vetres.org.)
Table II. Up regulation of MHC II and CD86 upon TLR ligation.
P3C
c PIC
c LPS
c Imi
c CpG odn
c
ﬁ
a p
b ﬁ p ﬁ p ﬁ p ﬁ p
MoDC CD86 3.6 0.048 3.9 0.003 3.2 0.038 1.1 0.3 2.6 0.14
MoDC MHC II 2.0 0.019 2.4 0.012 2.1 0.018 1.4 0.029 1.6 0.2
FL-BMDC CD86 4.7 0.046 3.9 0.047 3.6 0.037 3.2 0.039 2.1 0.11
FL-BMDC MHC II 2.1 0.008 2.0 0.001 2.5 0.008 2.2 0.009 1.2 0.2
GM-BMDC CD86 1.8 0.08 1.5 0.04 1.5 0.02 1.3 0.07 0.9 0.28
GM-BMDC MHC II 1.8 0.049 1.6 0.039 1.6 0.001 1.4 0.046 0.9 0.81
a Average fold increase of mean ﬂuorescent intensity (MFI) calculated as MFI of stimulated cells/MFI of
unstimulated cells (n = 5).
b p value determined by one-sample t-test.
c P3C = Pam3Cys; PIC = Polyinosinic-Polycytidylic; Imi = Imiquimod; and CpG odn = CpG oligonucleotide
ODN 2395.
Canine dendritic cells Vet. Res. (2010) 41:40
(page number not for citation purpose) Page 9 of 12anaemia [11], myopathy [44] and infectious dis-
eases [12]. Considering the importance of DC
in these diseases, the present study character-
ized the canine DC system in more detail.
Our aim was not only to establish and optimize
culture systems which allow the efﬁcient gener-
ation of large numbers of DC but also to obtain
information on the phenotype and function of
canine DC, and to ﬁnd discriminatory DC
markers. Our study conﬁrms previous studies
that have classiﬁed canine DC as CD1c
+,
CD11c
+,M H CI I
+,C D 8 0
+,C D 8 6
+ and
CD40
+ cells [1, 7, 9, 17, 38, 39]. However,
our comparative analysis to monocytes and
MU, which has not been systematically per-
formed before, demonstrated that none of the
markers typically used to differentiate DC from
monocytes/MU including CD1c, CD11b,
CD11c and CD14 permits to identify canine
DC when used alone. This broad expression
of CD11c and its unsuitability as a DC marker
was also found with porcine DC and contrasts
with the mouse DC system in which CD11c
represents a marker frequently used to differen-
tiate DC from monocytes, granulocytes and
macrophages. Canine monocyte-derived MU
can be phenotypically distinguished from
monocytes by their expression of CD1c and
the mannose receptor CD206, representing a
C-type lectin receptor. However, the speciﬁcity
of the aCD1c antibody used is currently under
debate, since it might bind to CD1a instead of
CD1c [21]. CD206 was also able to discrimi-
nate MoDC and MU, this time with expression
restricted to the MU.H o w e v e r ,B M D Ca l s o
expressed CD206 which is in agreement with
observations done in other species where this
c-type lectin can also be found on both MU
and DC [10, 34, 41]. Based on our data demon-
strating CD40 expression even on unstimulated
MoDC and BMDC, but not on MU and mono-
cytes, we propose that this surface molecule is a
potential discriminatory marker for DC.
In humans, CD14 is considered to be a typ-
ical monocyte/MU rather than a DC marker [3].
Therefore, it was unexpected to ﬁnd CD14
expressed on all DC cultures, although at lower
levels when compared to MU. Nevertheless,
this ﬁnding is consistent with previous observa-
tions for dogs [7, 17], pigs [8], cattle [16],
chimpanzees [4] and cats [6]. In contrast,
CD14 was described to be absent from canine
blood DC [24], again being comparable to the
porcine DC system [34].
An interesting observation was the expres-
sion of CD4 and CD8 found on BMDC but
not on blood-derived cells. CD4 and CD8 is
also found on particular murine DC subsets
but the function of these receptors for DC is
unknown [14]. Also the differential expression
of CD45RA only found on SC
low FL-BMDC
deserves further investigation focusing on a dif-
ferential expression of these markers on DC
in vivo.
An important functional criterion of DC
related to their important role in innateimmunity
is the response to many TLR ligands in terms of
maturation and cytokine production. Using this
criterion, we demonstrate that LPS-stimulated
MoDC in contrast to MU up-regulated MHC
II, CD80 and CD40, similar to observations
found with other species [3, 8, 33] upon stimu-
lation with ligands to TLR2, -3 and -7 MoDC
reacted with a signiﬁcant up regulation of
MHC II and CD86 as seen in other species
[27, 34, 42]. The lack of responsiveness to
TLR9 ligand CpG could be related to observa-
tions also found for humans and pigs, which
describe that only plasmacytoid DC express this
receptor [34, 40]. Future studies are required
with more CpG sequences and the canine
plasmacytoid DC need to be identiﬁed before
any conclusion can be drawn. GM-BMDC
expressed the highest levels of CD86 and
MHC II, which did not often further increase
upon stimulation indicating a spontaneous mat-
uration in this cell culture system. This con-
trasted with FL-BMDC which remained in an
immature phenotype and showed the most
potent up regulation of MHC II and CD86 after
stimulation with TLR2, -3, -4 and -7 ligands.
This may relate to the central role of Flt3L in
the generation of steady state DC from a clono-
genic bone marrow DC precursor, whereas
GM-CSF is important for the generation of
inﬂammatory monocyte-derived DC [23, 26].
In the MLR, all DC stimulated lymphocytes.
As expected, activated DC showed a signiﬁ-
cantly higher stimulatory capacity compared
to their unstimulated counterparts. All together
Vet. Res. (2010) 41:40 M.E. Ricklin Gutzwiller et al.
Page 10 of 12 (page number not for citation purpose)the relative efﬁciency of the different cells ana-
lyzed to induce T cell proliferation correlated
with their expression of MHC II.
Taken together, the present study provides a
detailed characterization of the phenotypic and
functional properties of canine DC generated
in vitro, which represent a valuable system for
studying the interaction of DC with pathogens
and their role in tumor immunology, autoimmu-
nity and allergy. We also propose that these cul-
tures contain various DC subsets with potential
equivalents in vivo with distinct functions in
steady state conditions and inﬂammation, as
well as with different anatomical localizations.
Future studies are required to identify these sub-
sets in vivo, and to study their contribution to
immune response against infectious agents as
well as during allergies and autoimmune
diseases.
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